title: Effects of natural compounds on Xenopus embryogenesis: a potential read out for functional drug discovery targeting Wnt/β-catenin signaling.
abstract: Maternal Wnt/β-Catenin signaling is essential to establish dorsal-specific gene expression required for axial patterning in Xenopus. Deregulation of this pathway causes axis phenotypes in frog embryos. In adult life, mutations in the Wnt pathway components are associated with many diseases, such as polyposis coli; osteoporosis-pseudoglioma syndrome (OPPG); skeletal dysplasia; neural tube defects, cancer and many others. Thus, a better understanding of Wnt/β-catenin signaling will have great and significant impact on Biology and Medicine. In this aspect, natural compounds are potential targets as novel molecules that could modulate the Wnt pathway. For instance, flavonoids are a large group of natural compounds found in plants that modulate important cellular and molecular mechanisms related to diseases, but the specific in vivo mechanism of action of most flavonoids remain unknown. In this way, Xenopus embryos may provide an efficient model, since it is frequently used to test and identify the role of molecules that affect Wnt/β-catenin signaling. Here, we describe a combination of approaches to outline and characterize the role of two flavonoids, quercetin and rutin, on Wnt/β-catenin signaling, using Xenopus embryos as an experimental model. Our data support that quercetin is potential in vivo modulator of canonical Wnt signaling and that this effect might depend on the structure of this molecule, as we did not observe any effect with rutin treatment, a flavonol structurally-related to quercetin. This model is useful to analyze effects of quercetin and other flavonoids in vivo and to provide further understanding of how natural compounds can modulate signaling pathways, using Xenopus embryos as a fast and efficient reading of in vivo effects of those compounds.
authors.affiliation: Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
authors.forename: Nathalia G
authors.initials: NG
authors.lastname: Amado
authors.forename: Barbara F
authors.initials: BF
authors.lastname: Fonseca
authors.forename: Debora Malta
authors.initials: DM
authors.lastname: Cerqueira
authors.forename: Alice H
authors.initials: AH
authors.lastname: Reis
authors.forename: Alessandro Bolis Costa
authors.initials: AB
authors.lastname: Simas
authors.forename: Ricardo Machado
authors.initials: RM
authors.lastname: Kuster
authors.forename: Fabio A
authors.initials: FA
authors.lastname: Mendes
authors.forename: Jose G
authors.initials: JG
authors.lastname: Abreu
mesh_terms: D000818:Animals; D001483:Base Sequence; D001688:Biological Products / Q000494:pharmacology*; D017931:DNA Primers; D055808:Drug Discovery; D047108:Embryonic Development / Q000187:drug effects*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000187:drug effects*; D051153:Wnt Proteins / Q000378:metabolism*; D014981:Xenopus / Q000196:embryology*; D051176:beta Catenin / Q000378:metabolism*
chemical_list: D001688:Biological Products; D017931:DNA Primers; D051153:Wnt Proteins; D051176:beta Catenin